Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Minoxidil and finasteride treat hair loss; more research needed for other options.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Platelet Rich Plasma (PRP) treatment is safe and effective for hair growth in people with androgenic alopecia, and can also help treat bacterial infections.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Both mouse and rat models are effective for testing alopecia areata treatments.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

A portable device can create nanofibers to improve the appearance of thinning hair better than commercial products.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.